Cargando…

Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen

A novel betacoronavirus (SARS-CoV-2) that causes severe pneumonia emerged through zoonosis in late 2019. The disease, referred to as COVID-19, has an alarming mortality rate and it is having a devastating effect on the global economy and public health systems. A safe, effective vaccine is urgently n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srivastava, Vikram, Niu, Ling, Phadke, Kruttika S., Bellaire, Bryan H., Cho, Michael W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991075/ https://www.ncbi.nlm.nih.gov/pubmed/33777030 http://dx.doi.org/10.3389/fimmu.2021.637982

Ejemplares similares

A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain
por: Niu, Ling, et al.
Publicado: (2021)

A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding
por: Yang, Jing, et al.
Publicado: (2022)

Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2021)

Single Domain Antibody application in bacterial infection diagnosis and neutralization
por: Qin, Qian, et al.
Publicado: (2022)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021)

Immunogenicity of SARS-CoV: the Receptor-Binding Domain of S Protein is a Major Target of Neutralizing Antibodies
por: He, Yuxian
Publicado: (2006)

A comparison of the binding sites of antibodies and single-domain antibodies
por: Gordon, Gemma L., et al.
Publicado: (2023)

Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer
por: Huang, Bilian, et al.
Publicado: (2021)

MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
por: Lee, Sua, et al.
Publicado: (2021)

rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis
por: Shen, Weiran, et al.
Publicado: (2022)

Sprayable copper and copper–zinc nanowires inks for antiviral surface coating
por: Pan, Chaochao, et al.
Publicado: (2022)

SARS-CoV-2 Is More Efficient than HCoV-NL63 in Infecting a Small Subpopulation of ACE2+ Human Respiratory Epithelial Cells
por: Castillo, Gino, et al.
Publicado: (2023)

SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2022)

Combinatorial Strategies for the Induction of Immunogenic Cell Death
por: Bezu, Lucillia, et al.
Publicado: (2015)

Immunogenic Cell Death Induction by Ionizing Radiation
por: Zhu, Mengqin, et al.
Publicado: (2021)

A potent human neutralizing antibody Fc-dependently reduces established HBV infections
por: Li, Dan, et al.
Publicado: (2017)

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
por: Wrapp, Daniel, et al.
Publicado: (2020)

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
por: Wrapp, Daniel, et al.
Publicado: (2020)

Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis
por: Shen, Weiran, et al.
Publicado: (2023)

Enhanced apoptosis as a possible mechanism to self-limit SARS-CoV-2 replication in porcine primary respiratory epithelial cells in contrast to human cells
por: Nelli, Rahul K., et al.
Publicado: (2021)

Potent Neutralization of Botulinum Neurotoxin/B by Synergistic Action of Antibodies Recognizing Protein and Ganglioside Receptor Binding Domain
por: Chen, Changchun, et al.
Publicado: (2012)

CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques
por: Sarkar, Sanghita, et al.
Publicado: (2021)

Immune Response to Therapeutic Staphylococcal Bacteriophages in Mammals: Kinetics of Induction, Immunogenic Structural Proteins, Natural and Induced Antibodies
por: Kaźmierczak, Zuzanna, et al.
Publicado: (2021)

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
por: Favorskaya, Irina A., et al.
Publicado: (2022)

SARS-CoV-2 tetrameric RBD protein blocks viral infection and induces potent neutralizing antibody response
por: Liu, Zheng, et al.
Publicado: (2022)

Intratumoral STING activation causes durable immunogenic tumor eradication in the KP soft tissue sarcoma model
por: Marritt, Kayla L., et al.
Publicado: (2023)

Corrigendum: “Combinatorial Strategies for the Induction of Immunogenic Cell Death”
por: Bezu, Lucillia, et al.
Publicado: (2015)

Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition
por: Maciola, Agnieszka Katarzyna, et al.
Publicado: (2022)

A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of Concern
por: Ahmed, Shahbaz, et al.
Publicado: (2021)

The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage
por: Zhou, Jeffrey O., et al.
Publicado: (2020)

Ontogeny‐based immunogens for the induction of V2‐directed HIV broadly neutralizing antibodies
por: Moore, Penny L., et al.
Publicado: (2017)

Dichotomy in Neutralizing Antibody Induction to Peptide-Conjugated Vaccine in Squalene Emulsion Contrast With Aluminum Hydroxide Formulation
por: Bonduelle, Olivia, et al.
Publicado: (2022)

Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains
por: Yasamut, Umpa, et al.
Publicado: (2019)

A novel single-domain antibody multimer that potently neutralizes tetanus neurotoxin
por: de Smit, Hans, et al.
Publicado: (2021)

The N-terminal domain of a tick evasin is critical for chemokine binding and neutralization and confers specific binding activity to other evasins
por: Eaton, James R. O., et al.
Publicado: (2018)

Corrigendum: The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage
por: Zhou, Jeffrey O., et al.
Publicado: (2020)

Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses
por: Beltran-Pavez, Carolina, et al.
Publicado: (2022)

A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters
por: Fagre, Anna C., et al.
Publicado: (2020)

Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy
por: Chanzu, Nadia, et al.
Publicado: (2014)

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies
por: Carrico, CT, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_24hvcarsuqeemmkp4fnmegnukm